Intragastric balloons for the temporary management of morbid obesity
Ivan M, Wang S, Newton S, Zimprich C, Sullivan T, Merlin T, Hiller JE
Record ID 32012000219
English
Original Title:
Application 1112
Authors' results and conclusions:
Safety - Intragastric balloons (IGB) are invasive procedures compared with conventional obesity therapies such as diet, exercise or behaviour modification, and therefore are associated with an increased risk of adverse events. Complications may occur either during the placement/removal of the IGB or during the IGB treatment. Although rare, major complications (including death) associated with the procedure have been reported in the literature. Minor complications have also been associated with IGB treatment. Effectiveness - IGBs in combination with conventional obesity therapies are effective in assisting weight loss in morbidly obese patients. However, it is unclear whether IGBs provide any additional benefit over conventional obesity therapies. Furthermore, there is little evidence regarding whether weight loss that could be attributed to IGBs is sustained in the long term. More evidence is needed to assess the impact of IGBs, in addition to diet, in both short- and long-term weight loss in morbidly obese patients. Economics - The available evidence on safety and effectiveness did not allow a formal economic analysis to be undertaken at this time. The financial evaluation undertaken was based on an assessment of expenditures associated with the placement/removal of IGBs and an estimate of the total cost to the Australian healthcare system. The overall financial impact of this procedure to the Australian health system is estimated to be between $19,236,067 and $30,535,600 per year, of which $2,812,021 to $4,511,328 would be borne by the Australian Government.
Details
Project Status:
Completed
Year Published:
2008
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/2E8614C59CD3F84BCA25801000123B54/$File/1112-Assessment-Report.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Obesity, Morbid
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.